000			01575 a2200421 4500
005			20250513225236.0
264		0	_c20010517
008			200105s 0 0 eng d
022			_a0027-8874
024	7		_a10.1093/jnci/92.24.1968 _2doi
040			_aNLM _beng _cNLM
100	1		_aNelson, N J
245	0	0	_aTrial data lacking for elderly patients with breast cancer. _h[electronic resource]
260			_bJournal of the National Cancer Institute _cDec 2000
300			_a1968-9 p. _bdigital
500			_aPublication Type: News
650	0	4	_aAge Distribution
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant _xstandards
650	0	4	_aClinical Trials as Topic _xstatistics & numerical data
650	0	4	_aConsensus Development Conferences, NIH as Topic
650	0	4	_aEstrogen Receptor Modulators _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKarnofsky Performance Status
650	0	4	_aMiddle Aged
650	0	4	_aNational Institutes of Health (U.S.)
650	0	4	_aRadiotherapy, Adjuvant _xstandards
650	0	4	_aSurvival Analysis
650	0	4	_aUnited States
773	0		_tJournal of the National Cancer Institute _gvol. 92 _gno. 24 _gp. 1968-9
856	4	0	_uhttps://doi.org/10.1093/jnci/92.24.1968 _zAvailable from publisher's website
999			_c11062048 _d11062048